This report is designed to give the sector insight into the challenges, enablers and a path forward to routine collection of stage and recurrence Australian breast cancer data. Findings are drawn from a national roundtable attended by key cancer sector stakeholders, population based cancer registry representatives, clinical professional bodies and policymakers in August 2023. All quotes contained in this report are attributed to attendees of the roundtable.